News & Updates

Gratitude is associated with increased longevity among older females, a population-based study has shown. 

Two years of treatment with the monoclonal IgG1 antibody bimekizumab led to minimal spinal radiographic progression in patients with radiographic axial spondyloarthritis (r-axSpA) in the open-label extension (OLE) of the phase III BE MOBILE 2 study.

Researchers from the Chinese University of Hong Kong (CUHK) have developed an artificial intelligence (AI)–powered app and actigraphy that effectively diagnoses depression by analyzing rest-activity, facial expression, mood, and voice.

Patients with moderate-to-severe Crohn’s disease (CD) with delayed response to adalimumab or ustekinumab display similar 1-year clinical outcomes to those with an early response, reports a study.

A retrospective cohort study evaluating participants from Catalonia, Spain reinforces the potential of immunoprophylaxis with the novel monoclonal antibody nirsevimab in combating respiratory syncytial virus (RSV)-related outcomes in infants in the hospital and primary care settings.